IVERIC bio, Inc. (ISEE) Social Stream
IVERIC BIO INC (ISEE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering IVERIC BIO INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-13 | 4 | $25 | $20 | $22 | $39.95 | -44.93% |
| 2021-11-10 | 4 | $26 | $21 | $23.5 | $39.95 | -41.18% |
| 2022-01-13 | 5 | $26 | $22 | $23.75 | $39.95 | -40.55% |
| 2022-02-25 | 5 | $26 | $22 | $24 | $39.95 | -39.92% |
| 2022-03-03 | 6 | $27 | $22 | $24.5 | $39.95 | -38.67% |
| 2022-05-05 | 7 | $27 | $22 | $24.857 | $39.95 | -37.78% |
| 2022-05-12 | 8 | $28 | $12 | $24 | $39.95 | -39.92% |
| 2022-06-09 | 10 | $30 | $12 | $24 | $39.95 | -39.92% |
| 2022-07-27 | 11 | $30 | $12 | $24.5 | $39.95 | -38.67% |
| 2022-08-13 | 11 | $30 | $12 | $24.09 | $39.95 | -39.7% |
| 2022-09-06 | 11 | $30 | $12 | $24.545 | $39.95 | -38.56% |
| 2022-09-17 | 11 | $35 | $8 | $26.636 | $39.95 | -33.33% |
| 2022-10-17 | 11 | $35 | $19 | $28.272 | $39.95 | -29.23% |
| 2022-11-03 | 11 | $35 | $19 | $28.636 | $39.95 | -28.32% |
| 2022-11-07 | 11 | $35 | $17 | $29.272 | $39.95 | -26.73% |
| 2022-11-28 | 10 | $35 | $17 | $28.363 | $39.95 | -29% |
| 2023-01-06 | 11 | $35 | $17 | $28.363 | $39.95 | -29% |
| 2023-01-26 | 11 | $35 | $17 | $28.545 | $39.95 | -28.55% |
| 2023-02-08 | 11 | $35 | $17 | $28.636 | $39.95 | -28.32% |
| 2023-02-16 | 10 | $35 | $17 | $28.636 | $39.95 | -28.32% |
| 2023-02-21 | 10 | $35 | $17 | $28.727 | $39.95 | -28.09% |
| 2023-03-01 | 11 | $35 | $19 | $29.181 | $39.95 | -26.96% |
| 2023-04-20 | 11 | $40 | $19 | $29.636 | $39.95 | -25.82% |
| 2023-04-24 | 11 | $40 | $19 | $30.636 | $39.95 | -23.31% |
| 2023-04-27 | 11 | $40 | $19 | $31.545 | $39.95 | -21.04% |
| 2023-05-01 | 10 | $40 | $19 | $32.454 | $39.95 | -18.76% |
| 2023-05-02 | 10 | $40 | $19 | $34.454 | $39.95 | -13.76% |
| 2023-05-04 | 10 | $40 | $19 | $36.818 | $39.95 | -7.84% |
| 2023-05-17 | 10 | $40 | $31 | $38.727 | $39.95 | -3.06% |
The Trend in the Analyst Price Target
ISEE's average price target has moved up $14.64 over the prior 41 weeks.
Over the past 42 weeks, ISEE's average upside potential has been 31.72%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-02 | 11 | 30 | 12 | 24.090 | 11.01 | 118.8% |
| 2022-09-17 | 11 | 35 | 8 | 26.636 | 17.62 | 51.17% |
| 2022-10-17 | 11 | 35 | 19 | 28.272 | 21.91 | 29.04% |
| 2023-02-16 | 10 | 35 | 17 | 28.636 | 20.00 | 43.18% |
| 2023-05-08 | 10 | 40 | 31 | 38.727 | 37.69 | 2.75% |
ISEE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 9 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 43 weeks, ISEE's average broker recommendation rating worsened by 1.5.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how IVERIC BIO INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 138.21% of that group.
- IVERIC BIO INC's number of analysts covering the stock is higher than 2425.45% of stocks in the mid market cap category.
- IVERIC BIO INC's variance in analysts' estimates is lower than -1977.58% of stocks in the mid market cap category.
- IVERIC BIO INC's average analyst price target is higher than 1429.11% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to IVERIC BIO INC are PBYI, PCRX, and EBS.
View All Top Stocks by Price Target
Is ISEE a Buy, Hold or Sell? See the POWR Ratings now!